LAMICTAL 50 mg, dispersible or chewable tablet 30 tablets, CIP 3400930225127
Brand page: Lamictal (lamotrigine) — all forms and strengths in France
Active ingredients: Lamotrigine
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible or chewable tablet30 tablets, CIP 3400930225127orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMICTAL 50 mg, comprimé dispersible ou à croquer
- Pharmaceutical form
- comprimé dispersible ou à croquer
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium papier avec fermeture de sécurité enfant de 30 comprimé(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jun 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67326619CIP73022512CIP133400930225127Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LAMOTRIGINEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.